Alain Bitton
Professor, Department of Medicine, McGill University
MD, CM
McGill University - Gastroenterology
Harvard University, Beth Israel Deaconess Medical Center - Inflammatory Bowel Disease
Inflammatory Bowel Disease, General Gastroenterology
Dr. Alain Bitton is Professor of Medicine and the Director of the Division of Gastroenterology and Hepatology, McGill University and McGill University Health Centre (MUHC). Previously he was the McGill Gastroenterology Residency Program Director. His research in Inflammatory Bowel Disease (IBD) includes identifying factors that predict disease course and recurrence and defining the epidemiology of IBD in Quebec. He is the Quebec clinical lead of the Quebec IBD Genetics consortium (QIGC) part of the University of Montreal Genetic Research Centre (GRC) which is one of the 6 GRCs making up the NIH-NIDDK IBD Genetics Consortium which has identified IBD susceptibility genes. He has championed the creation of the MUHC’s IBD center, a multidisciplinary platform for healthcare delivery, research and education. He spearheaded the development of a tool to be used for ongoing assessment and improvement of care of IBD patients in Canada.
- Bitton A, Devitt K, Bressler B et al. Development of a Global Rating Scale for Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology. 2020 Feb ; 3: 4–16,
- Bitton A, Vutcovici M, Lytvyak E, Kachan N, Bressler B, Jones J, Lakatos PL, Sewitch M, El-Matary W, Melmed G, Nguyen G; QI consensus group on behalf of the Promoting Access and Care through Centers of Excellence-PACE program. Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives. Inflamm Bowel Dis. 2018 Aug 29. [Epub ahead of print]
- Bressler B, Marshall JK, Bernstein C, Bitton A, Jones J, Leontiadis G, Pannacione R, Steinhart H, Tse F, Feagan B. Clinical Practice Guidelines for the Medical Management on non-hospitalized ulcerative colitis. The Toronto Consensus. Gastroenterology 2015 May;148(5):1035-1058
- Bitton A, Vutcovici M, Patenaude V, Sewitch M, Suissa S, Brassard P. Epidemiology of inflammatory bowel disease in Québec: recent trends. Inflammatory Bowel Disease 2014 Oct 20(10):1770-6.
- Bitton A, Buie D, Enns R, Feagan BG, Jones JL, Marshall JK, Whittaker S, Griffiths AM, Panaccione R Treatment of hospitalized adult patients with severe ulcerative colitis: toronto consensus statements. Canadian Association of Gastroenterology Severe Ulcerative Colitis Consensus Group. Am J Gastroenterol. 2012 Feb;107(2):179-94.
- Bitton A, Dobkin P, Edwardes MD, Sewitch MJ, Meddings J, Vermeire S, Cohen A, Rawal S, Dufresne L, Franchimont D, Wild G. Predicting Relapse in Crohn's Disease: A Biopsychosocial Model. Gut 2008 Oct;57(10): 1386-92 (Accompanying editorial)
- Duerr RH, Taylor KD, Brant DR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW,. Kistner EO, Schumm LP, Lee A, Gregersen PK, Barmada MM. Rotter JI, Nicolae DL, Cho JH. Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene. Published online October 26 2006; 10.1126/science.1135245 (Science Express Reports)
- Bitton A, Sewitch MJ, Edwardes M, Peppercorn M, Shah S, Ransil B, Locke S. Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study. Am J Gastroenterol 2003;98:2203-08
- Bitton A, Peppercorn MA, Antonioli D, Niles JL, Shah S, Bousvaros A, M DeB Edwardes ,Ransil BJ, Wild G, Cohen A. Stevens AC. Clinical, Biological, and Histological Parameters as predictors of relapse in Ulcerative Colitis Gastroenterology 2001;119:13-19.